Woodmont Investment Counsel LLC Natera, Inc. Transaction History

Woodmont Investment Counsel LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$17.75 - $27.58 $198,125 - $307,847	-11,162 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$11.34 - $20.62 $112,266 - $204,138	-9,900 Reduced 47.0%	11,162 $230,000
Q4 2018 Feb 14, 2019	BUY	$12.32 - $24.38 $25,564 - $50,588	2,075 Added 10.93%	21,062 $294,000
Q3 2018 Nov 13, 2018	BUY	$18.82 - $28.96 $99,030 - $152,387	5,262 Added 38.34%	18,987 $455,000
Q2 2018 Aug 10, 2018	BUY	$8.79 - $19.98 $120,642 - $274,225	13,725 New	13,725 $258,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Woodmont Investment Counsel LLC, based on Form 13F filings with the SEC.

Stay updated on Woodmont Investment Counsel LLC with notifications on news.